Related Experiment Video
Updated: Jun 12, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Is motor reserve associated with a rapid progression of Parkinson disease?
Myung Jun Lee1, Kyoungjune Pak2, Jae-Hyeok Lee3
1Department of Neurology, Pusan National University Hospital, Pusan National University School of Medicine and Biomedical Research Institute, Busan, Republic of Korea.
Abstract:
BackgroundThe motor reserve estimates (MRes) derived from a residual approach correlate with motor severity in Parkinson's disease (PD), leaving the independent effect of motor reserve on clinical outcomes unclear.ObjectiveInvestigate the independent influence of motor reserve on the long-term outcome.MethodsUsing the Parkinson's Progression Markers Initiative (PPMI) and Pusan National University Hospital (PNUH) datasets, we investigated the association of MRes with progression of motor severity as well as risk of phenoconversion to Hoehn & Yahr (H&Y) stage 3. Two MRes types were calculated: (1) original MRes, negative conversion of standardized residuals from a generalized linear model (GLM) between putaminal dopamine transporter (DAT) levels and motor severity, and (2) modified MRes, standardized residuals from the GLM between original MRes and motor scores.ResultsOriginal MRes correlated with baseline motor scores, while modified MRes did not. Modified MRes in both cohorts were associated with a rapid increase in motor severity (linear mixed effect model, interaction between MRes and disease duration; PPMI, Movement Disorder Society sponsored Unified Parkinson Disease Rating Scale part III [MDS-UPDRS III], estimate 2.248 × 10-3, p < 0.001; PNUH, UPDRS III, estimate 0.027, p = 0.014) In both cohorts, Kaplan-Meier plots showed high modified MRes indicated higher risk of progression to H&Y stage 3. Mediation models using original MRes agreed that high MRes were associated with an accelerated increase in motor scores.ConclusionsIndependent of baseline motor severity, MRes were associated with rapid motor deterioration and high risk of progression to H&Y stage 3.
Insights
Motor reserve estimates (MRes) independently predict faster motor decline and increased risk of Hoehn & Yahr stage 3 progression in Parkinson's disease (PD). This finding clarifies the independent effect of motor reserve on clinical outcomes.
Area of Science:
- Neurology
- Neuroscience
- Biomedical Engineering
Background:
- Motor reserve estimates (MRes) derived from residual approaches correlate with motor severity in Parkinson's disease (PD).
- The independent effect of motor reserve on clinical outcomes in PD remains unclear.
Purpose of the Study:
- To investigate the independent influence of motor reserve on the long-term outcome of Parkinson's disease.
- To assess the association of MRes with motor severity progression and phenoconversion risk.
Main Methods:
- Utilized Parkinson's Progression Markers Initiative (PPMI) and Pusan National University Hospital (PNUH) datasets.
- Calculated two MRes types: original and modified, based on putaminal dopamine transporter (DAT) levels and motor severity.
- Employed linear mixed-effect models and Kaplan-Meier plots to analyze MRes association with motor progression and Hoehn & Yahr (H&Y) stage 3 risk.
Main Results:
- Modified MRes, unlike original MRes, did not correlate with baseline motor scores.
- Modified MRes in both cohorts were significantly associated with a rapid increase in motor severity over time.
- High modified MRes levels indicated a higher risk of progression to H&Y stage 3 in both patient groups.
Conclusions:
- Motor reserve estimates (MRes) are independently associated with accelerated motor deterioration in Parkinson's disease.
- Higher MRes predict an increased risk of progressing to Hoehn & Yahr stage 3, independent of baseline motor severity.
More Related Videos
04:08Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease
Published on: January 18, 2021
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Neural Regulation